Stay updated on Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial
Sign up to get notified when there's something new on the Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial page.

Latest updates to the Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAn NIH-wide notice about terminology changes appeared, and the site revision label changed from v3.7.1 to v3.7.2. The clinical-trial record remains unavailable behind a 403 error.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study details and navigation. This blocks access to the core content of the record, preventing users from viewing study information and related data.SummaryDifference18%

- Check47 days agoChange DetectedThe page's revision number was updated from v3.6.6 to v3.7.0, indicating an internal update to the record. No changes to visible content or study information are described.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page shows a revision tag updated from v3.6.5 to v3.6.6, indicating a software version upgrade.SummaryDifference0.0%

- Check68 days agoChange DetectedThe change adds '2017 ( U.S. NIH Grant/Contract )' to the study identifiers, indicating NIH funding for the SIENDO trial. This places NIH funding information within the study's funding/identification context.SummaryDifference0.0%

Stay in the know with updates to Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial page.